Peptides 20, 23, 24, and 25 also appeared to inhibit in a concentration-dependent manner, albeit to a lesser extent. HCV. Thus, identification of a broadly neutralizing antibody that recognizes a linear epitope is likely to be Nimesulide of significant benefit to future vaccine and therapeutic antibody development. Hepatitis C computer virus (HCV), a positive-strand RNA computer virus belonging to theFlaviviridaefamily, is the major cause of non-A, non-B viral hepatitis. HCV has infected approximately 200 million people worldwide and current estimates suggest that as many as 3 Nimesulide million individuals are newly infected each year (4). Approximately 80% of those infected fail to clear the computer virus; a chronic contamination ensues, frequently leading to severe chronic liver disease, cirrhosis, and hepatocellular carcinoma (2,41). Current treatments for chronic contamination are ineffective for approximately 50% of patients, and there is a pressing need to develop preventative and therapeutic vaccines. Due to the error-prone nature of the RNA-dependent RNA polymerase and the high replicative rate in vivo (30,46), HCV exhibits a high degree of genetic variability. Crucially, this propensity for genetic change allows the computer virus to respond to and overcome a variety of selective pressures, including host immunity and antiviral therapy (18,26,37,44,53). HCV can be classified into six genetically distinct genotypes and further subdivided into at least 70 subtypes, which differ by approximately 30% and 15% at the nucleotide level, respectively (59,61). A significant challenge for the development of vaccines will lie in identifying protective epitopes that are conserved in the majority of viral genotypes and subtypes. This problem is Rabbit Polyclonal to CYB5 usually compounded by the fact that this envelope proteins, the natural targets for the neutralizing response, are two of the most variable proteins (10). The envelope proteins E1 and E2 are responsible for cell binding and entry (5,8,16,51,57). They are N-linked glycosylated (23,31,43,62) transmembrane proteins with a N-terminal ectodomain and a C-terminal hydrophobic membrane anchor (12,21,22). In vitro expression experiments have shown that E1 and E2 proteins form a noncovalent heterodimer, which is usually proposed to be the functional complex on the computer virus surface (13,14,17,22). Due to the lack of an efficient culture system, the exact mechanism of viral entry is usually unknown. That said, there is mounting evidence that entry into isolated primary liver cells and cell lines requires conversation with the cell surface receptors CD81 and scavenger receptor class B type 1 (SR-B1) (7,8,19,58,66), although these receptors individually are not sufficient to allow viral entry. Current evidence suggests that cell-mediated immunity is usually pivotal Nimesulide in clearance and control of Nimesulide HCV replication in acute contamination (32,67). However, surrogate models of contamination, such as animal contamination and cell and receptor binding assays, have highlighted the potential role of antibodies in both acute and chronic contamination (6,24,25,36,55,57,63,68,69). It is important to note that not all antibodies that inhibit binding of computer virus ligand to cell and/or receptors in in vitro assays necessarily neutralize contamination. Unsurprisingly, antibodies able to inhibit binding to a cell receptor(s) and/or neutralize contamination recognize both linear and conformational epitopes. The majority of antibodies that demonstrate broad neutralization of contamination and/or inhibition of receptor binding are directed against conformational epitopes within E2 (1,9,33,34,36). Induction of antibodies recognizing conserved conformational epitopes is extremely relevant to vaccine design, but this is likely to show difficult, as the variable regions appear to be immunodominant (55). One such immunodominant linear epitope lies within the first hypervariable region (HVR-1) of E2 (68). The use of conserved HVR-1 mimotopes has been proposed to overcome problems of restricted specificity (11,56,70), but it is not yet known whether this approach will be successful..